Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detoxification of the Liver in Primary Sclerosing Cholangitis
NCT05835505Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Dec 2023
- Primary completion
- May 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Primary Sclerosing Cholangitis (PSC) comparing BRS201 Arm with Placebo Arm (2 arms). Primary endpoint: Alkaline Phosphatase at 4 weeks. Started Dec 2023; status: recruiting.
02
Drugs
BRS201
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT05835505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05835505.